ViewRay - MRIdian MRI-Guided Linac

Designed specifically for radiation oncology, MRIdian clinical use spans over six years of treating approximately 11,000* patients on more than 65 ICD-10 codes. Search hundreds of peer-reviewed articles and Congress proceedings for additional scientific information.

*Hospital reported and ViewRay internal data on file (as of October 2020).

* indicates required

Email Address *

First Name *

Last Name *

Role *

Company Name *

Address

Address Line 2

City

State/Province/Region

Postal / Zip Code

Country

Phone Number

Email Format

html
text

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of our products and services, assist with our promotional and marketing efforts, and provide content from third parties. Cookie Policy

RSS Webinar: Techniques and Results of Ablative Radiation Doses for Inoperable Pancreas Cancer

Webinar Description: Prospective evidence demonstrates that non-ablative radiation dose improves local control without a meaningful impact on overall survival for patients with inoperable pancreas cancer. While the prescribed dose has historically been constrained due nearby GI organs at risk, the development of advanced treatment techniques has enabled the safe delivery of ablative hypofractionated radiation therapy. Emerging evidence suggests that dose intensification in selected patients achieves significantly improved long-term local control and overall survival.

Presenters:

Michael Chuong, MD, Miami Cancer Institute

Ann Raldow, MD, UCLA John Ng, MD, Weill Cornell Medicine

Chris Crane, MD, Memorial Sloan Kettering Cancer Center

Moderated By: Michael Chuong, MD, Miami Cancer Institute

This webinar has been supported by an unrestricted grant from ViewRay. This event is under the directed supervision of AMEDCO and Sponsor has had no part in the planning or delivery process.

Bibliography

Global Info

Bibliography

Subscribe

Global Info

CUSTOMER LOGIN